Zoetis Inc (NYSE: ZTS) closed the day trading at $165.67 down -1.28% from the previous closing price of $167.81. In other words, the price has decreased by -$2.14 from its previous closing price. On the day, 4549973 shares were traded.
Ratios:
For a better understanding of ZTS, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 37.17 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 46.80. For the most recent quarter (mrq), Quick Ratio is recorded 2.00 and its Current Ratio is at 3.36. In the meantime, Its Debt-to-Equity ratio is 1.36 whereas as Long-Term Debt/Eq ratio is at 1.35.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on January 12, 2024, Reiterated its Buy rating but revised its target price to $215 from $195 previously.
On December 07, 2023, Exane BNP Paribas started tracking the stock assigning a Outperform rating and target price of $237.Exane BNP Paribas initiated its Outperform rating on December 07, 2023, with a $237 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 18 ’24 when Lagano Roxanne sold 923 shares for $173.33 per share. The transaction valued at 159,984 led to the insider holds 15,723 shares of the business.
Reed Willie M sold 1,370 shares of ZTS for $250,265 on Mar 11 ’24. The Director now owns 9,994 shares after completing the transaction at $182.68 per share. On Feb 20 ’24, another insider, PECK KRISTIN C, who serves as the Chief Executive Officer of the company, sold 13,000 shares for $187.20 each. As a result, the insider received 2,433,636 and left with 79,366 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZTS now has a Market Capitalization of 75.85B and an Enterprise Value of 80.57B. As of this moment, Zoetis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 32.67, and their Forward P/E ratio for the next fiscal year is 25.56. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.36. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.88 while its Price-to-Book (P/B) ratio in mrq is 15.20. Its current Enterprise Value per Revenue stands at 9.43 whereas that against EBITDA is 21.98.
Stock Price History:
Over the past 52 weeks, ZTS has reached a high of $201.92, while it has fallen to a 52-week low of $151.03. The 50-Day Moving Average of the stock is 186.46, while the 200-Day Moving Average is calculated to be 181.05.
Shares Statistics:
Over the past 3-months, ZTS traded about 2.58M shares per day on average, while over the past 10 days, ZTS traded about 4.26M shares per day. A total of 458.37M shares are outstanding, with a floating share count of 457.47M. Insiders hold about 0.09% of the company’s shares, while institutions hold 95.54% stake in the company. Shares short for ZTS as of Feb 29, 2024 were 3.77M with a Short Ratio of 1.46, compared to 2.96M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.82% and a Short% of Float of 0.82%.
Dividends & Splits
ZTS’s forward annual dividend rate is 1.56, up from 1.50 a year ago. Against a Trailing Annual Dividend Yield of 0.89%, it implies a Forward Annual Dividend Yield of 1.04%. The stock’s 5-year Average Dividend Yield is 0.62.
Earnings Estimates
Current recommendations for the stock of the company come from 10 analysts. On average, analysts expect EPS of $1.36 for the current quarter, with a high estimate of $1.45 and a low estimate of $1.3, while EPS last year was $1.31. The consensus estimate for the next quarter is $1.51, with high estimates of $1.58 and low estimates of $1.47.
Analysts are recommending an EPS of between $6.04 and $5.66 for the fiscal current year, implying an average EPS of $5.8. EPS for the following year is $6.48, with 17 analysts recommending between $6.99 and $6.17.
Revenue Estimates
8 analysts predict $2.17B in revenue for the current quarter. It ranges from a high estimate of $2.28B to a low estimate of $2.11B. As of the current estimate, Zoetis Inc’s year-ago sales were $2.01B, an estimated increase of 7.70% from the year-ago figure. For the next quarter, 8 analysts are estimating revenue of $2.32B, an increase of 7.30% less than the figure of $7.70% in the same quarter last year. There is a high estimate of $2.35B for the next quarter, whereas the lowest estimate is $2.29B.
A total of 16 analysts have provided revenue estimates for ZTS’s current fiscal year. The highest revenue estimate was $9.33B, while the lowest revenue estimate was $9.13B, resulting in an average revenue estimate of $9.19B. In the same quarter a year ago, actual revenue was $8.54B, up 7.50% from the average estimate. Based on 16 analysts’ estimates, the company’s revenue will be $9.84B in the next fiscal year. The high estimate is $10.16B and the low estimate is $9.6B. The average revenue growth estimate for next year is up 7.10% from the average revenue estimate for this year.
